Suchergebnisse - "Shiotsu, Shinsuke"

PubPharm (6)

1

Predictive value of p53 and AXL immunostaining for the efficacy of immune checkpoint inhibitor-based therapy after osimertinib treatment in patients with epidermal growth factor-mutant non-small cell lung cancer

enthalten in: Cancer immunology, immunotherapy : CII | 2023

von Morimoto, K. | Yamada, T. | Sawada, R. | +15

2

Exploratory analysis of immunochemotherapy compared to chemotherapy after EGFR-TKI in non-small cell lung cancer patients with EGFR mutation : A multicenter retrospective study

enthalten in: Thoracic cancer | 2023

von Hata, T. | Sakaguchi, C. | Hirano, K. | +11

3

High levels of AXL expression in untreated EGFR-mutated non-small cell lung cancer negatively impacts the use of osimertinib

enthalten in: Cancer science | 2023

von Yoshimura, A. | Yamada, T. | Serizawa, M. | +25

4

A Real-World Analysis of Immune Checkpoint Inhibitor-Based Therapy After Osimertinib Treatment in Patients With EGFR-Mutant NSCLC

enthalten in: JTO clinical and research reports | 2022

von Morimoto, K. | Sawada, R. | Yamada, T. | +15

5

Impact of tumor programmed death ligand-1 expression on osimertinib efficacy in untreated EGFR-mutated advanced non-small cell lung cancer : a prospective observational study

enthalten in: Translational lung cancer research | 2021

von Yoshimura, A. | Yamada, T. | Okuma, Y. | +21

6

Retrospective efficacy analysis of immune checkpoint inhibitors in patients with EGFR-mutated non-small cell lung cancer

enthalten in: Cancer medicine | 2019

von Yamada, T. | Hirai, S. | Katayama, Y. | +14

1
[1]